PARK7 and Alzheimer disease: Matthias Mann's team identified more than 20 cerebrospinal fluid proteins and a series of potential candidate biomarkers including tau, SOD1, PARK7, and YKL‐40 that were associated with AD pathology in three independent cohorts.10